A team of researchers with Texinov Medical Textiles in France has announced that their PHOS-ISTOS system, called the Fluxmedicare, is on track to be made commercially available later this year. The system consists of a piece ...
Nearly three in 10 Medicare beneficiaries have at least one actinic keratosis diagnosis encounter over five years of follow-up, according to a research letter published online July 27 in JAMA Dermatology.
Aug 16, 2022
0
12
(HealthDay)—In a consensus statement published online Sept. 1 in JAMA Dermatology, recommendations are presented for prevention strategies for cutaneous squamous cell carcinoma (CSCC) in solid organ transplant recipients ...
Sep 2, 2021
0
5
(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year, according to a ...
Feb 11, 2021
0
1
(HealthDay)— For all of those men who view a mustache as a largely ornamental addition to their masculine appearance, a new study reveals it can also guard against lip cancer.
May 21, 2019
0
5
A treatment previously shown to clear the precancerous skin lesions called actinic keratosis now appears to reduce the chance that the treated skin will develop squamous cell carcinomas (SCCs), the second most common form ...
Mar 21, 2019
0
20
(HealthDay)—For patients with multiple actinic keratosis lesions on the head, 5 percent fluorouracil cream is the most effective treatment, according to a study published in the March 7 issue of the New England Journal ...
Mar 7, 2019
0
5
A new method of using a Scottish company's portable microwave technology to treat sun-damaged skin conditions is being tested by researchers at the University of Dundee.
Nov 9, 2018
0
1
A combination of two FDA-approved drugs - a topical chemotherapy and an immune-system-activating compound - was able to rapidly clear actinic keratosis lesions from patients participating in a clinical trial. Standard treatment ...
Dec 19, 2016
0
211
A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine ...
Nov 21, 2016
0
57
